Aarti Drugs Ltd - ESG Rating & Company Profile powered by AI
This webpage of Aarti Drugs Ltd is prepared by All Street Sevva using leading Cognitive Robots. If you are employed by Aarti Drugs Ltd and you wish to use your ESG aseessment, please contact us. Jump to the end of this webpage for potential risks for Aarti Drugs Ltd based on industry, geography and size.
Aarti Drugs Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.3; made up of an environmental score of 2.0, social score of 3.2 and governance score of 1.6.
2.3
Low ImpactEnvironmental
Social
Governance
![Detailed ESG Breakdown](/resource/detailed-esg.png?ts=1725478325797)
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1512 | Sol Gel Technologies Ltd | 2.4 | Medium |
1512 | Windtree Therapeutics Inc | 2.4 | Medium |
1529 | Aarti Drugs Ltd | 2.3 | Medium |
1529 | ANI Pharmaceuticals Inc | 2.3 | Medium |
1529 | Angion Biomedica Corp | 2.3 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
![Peer Companies Benchmark](/resource/peer-benchmark-2.png?ts=1725478325797)
Frequently Asked Questions
Does Aarti Drugs Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Aarti Drugs Ltd disclose current and historical energy intensity?
Does Aarti Drugs Ltd report the average age of the workforce?
Does Aarti Drugs Ltd reference operational or capital allocation in relation to climate change?
Does Aarti Drugs Ltd disclose its ethnicity pay gap?
Does Aarti Drugs Ltd disclose cybersecurity risks?
Does Aarti Drugs Ltd offer flexible work?
Does Aarti Drugs Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Aarti Drugs Ltd disclose the number of employees in R&D functions?
Does Aarti Drugs Ltd conduct supply chain audits?
Does Aarti Drugs Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Aarti Drugs Ltd conduct 360 degree staff reviews?
Does Aarti Drugs Ltd disclose the individual responsible for D&I?
Does Aarti Drugs Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Aarti Drugs Ltd disclose current and / or historical scope 2 emissions?
Does Aarti Drugs Ltd disclose water use targets?
Does Aarti Drugs Ltd have careers partnerships with academic institutions?
Did Aarti Drugs Ltd have a product recall in the last two years?
Does Aarti Drugs Ltd disclose incidents of discrimination?
Does Aarti Drugs Ltd allow for Work Councils/Collective Agreements to be formed?
Has Aarti Drugs Ltd issued a profit warning in the past 24 months?
Does Aarti Drugs Ltd disclose parental leave metrics?
Does Aarti Drugs Ltd disclose climate scenario or pathway analysis?
Does Aarti Drugs Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Aarti Drugs Ltd disclose the pay ratio of women to men?
Does Aarti Drugs Ltd support suppliers with sustainability related research and development?
Does Aarti Drugs Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Aarti Drugs Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Aarti Drugs Ltd involved in embryonic stem cell research?
Does Aarti Drugs Ltd disclose GHG and Air Emissions intensity?
Does Aarti Drugs Ltd disclose its waste policy?
Does Aarti Drugs Ltd report according to TCFD requirements?
Does Aarti Drugs Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Aarti Drugs Ltd disclose energy use targets?
Does Aarti Drugs Ltd disclose its Renewable Energy targets?
![Only Subscribers](/resource/reload.png)
Are emissions metrics verified by STBi?
![Only Subscribers](/resource/reload.png)
Does Aarti Drugs Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Aarti Drugs Ltd
These potential risks are based on the size, segment and geographies of the company.
Aarti Drugs Limited, through its subsidiaries, engages in the pharmaceuticals business in India and internationally. The company offers active pharmaceutical ingredients in various therapeutic categories, including anti-inflammatory, cardioprotectants, antidiarrhoeals, antifungals, antiarthritis/osteoporosis, antibiotics, antidiabetics, Alzheimer's treatment, sedatives, vitamins, and alcoholism treatment; and pharmaceutical intermediate products comprising tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, nimesulide, and raloxifene. It also offers specialty chemical products, such as benzene sulphonamide, benzene sulphonic acid, benzene sulphonic acid methyl ester, benzene sulphonyl chloride, cipro Q acid, levofloxacin Q acid, methyl nicotinate, N-methyl methane sulphonamide, diphenyl sulphone, norofloxacin Q acid, ofloxacin Q acid, ortho para toluene sulphonamide, ortho/para toluene sulphonic acid methyl ester, para chloro benzene sulphonamide, para chloro benzene sulphonyl chloride, para toluene sulphonamide, para toluene sulphonic acid methyl ester, para toluene sulphonyl chloride, and sodium benezene sulfinate, as well as para toluene sulphonyl hydrazide and benzene sulphonic acid and sodium salt; and benzyl nicotinate, bisphenol " C, bisphenol " C(chloride), ethyl nicotinate, ethyl para toluene sulphonate, and N-methyl imidazole. In addition, the company's products under development comprise Acamprosate for alcoholism; Dabigatran for use as an anticoagulant; Sevelamer for antihyperphosphatemia; Colsevelam for anti-cholestrol treatment; Drondarone and Olmesartan for the treatment of cardiovascular diseases; Valasartan for use as cardiprotectant; and Sitagliptin for use as an antidiabetic. Further, it offers contract manufacturing services. The company was incorporated in 1984 and is headquartered in Mumbai, India.